Cardiovascular drug therapy in the elderly
- PMID: 11728253
Cardiovascular drug therapy in the elderly
Abstract
Cardiovascular diseases of various etiologies are most prevalent in the elderly, and there are many pharmacologic issues that need to be considered when prescribing drug therapies to this population. Aging itself alters the absorption, distribution, metabolism, and excretion of many drugs. Certain drugs, such as digoxin, lidocaine, and warfarin, need to be used with great caution in older patients because of a greater potential for drug toxicity. Elderly patients often are prescribed multiple drugs for different conditions, making them susceptible to major drug-drug interactions. Recommendations are provided to help ensure safe prescribing practices of cardiac drugs in older patients.
Similar articles
-
Cardiovascular drug therapy in the elderly.Cardiol Rev. 2007 Jul-Aug;15(4):195-215. doi: 10.1097/CRD.0b013e3180301b69. Cardiol Rev. 2007. PMID: 17575484 Review.
-
Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.J Clin Pharm Ther. 2007 Apr;32(2):169-75. doi: 10.1111/j.1365-2710.2007.00815.x. J Clin Pharm Ther. 2007. PMID: 17381667
-
[Cardiological drugs and the elderly].Ann Cardiol Angeiol (Paris). 1997 Jul-Sep;46(7):461-8. Ann Cardiol Angeiol (Paris). 1997. PMID: 9452781 Review. French.
-
Cardiovascular drugs and the elderly population.Heart Lung. 1982 Sep-Oct;11(5):430-4. Heart Lung. 1982. PMID: 6921190 No abstract available.
-
Gender-specific implications for cardiovascular medication use in the elderly optimizing therapy for older women.Cardiol Rev. 2003 Sep-Oct;11(5):275-98. doi: 10.1097/01.crd.0000078842.86834.93. Cardiol Rev. 2003. PMID: 12943605 Review.
Cited by
-
Atrial Fibrillation: The New Epidemic of the Ageing World.J Atr Fibrillation. 2009 Apr 1;1(6):154. doi: 10.4022/jafib.154. eCollection 2009 Apr-May. J Atr Fibrillation. 2009. PMID: 28496617 Free PMC article. Review.
-
Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines.Clin Pharmacokinet. 2002;41(7):505-16. doi: 10.2165/00003088-200241070-00004. Clin Pharmacokinet. 2002. PMID: 12083978 Review.
-
Aspirin for the prevention of cardiovascular events in the elderly.Drugs Aging. 2003;20(13):999-1010. doi: 10.2165/00002512-200320130-00004. Drugs Aging. 2003. PMID: 14561103 Review.
-
Pharmacokinetic considerations for digoxin in older people.Open Cardiovasc Med J. 2011;5:130-5. doi: 10.2174/1874192401105010130. Epub 2011 Jun 15. Open Cardiovasc Med J. 2011. PMID: 21769303 Free PMC article.